Society of Nuclear Medicine offers free access to Journal of Nuclear Medicine

September 05, 2006

RESTON, Va. -- SNM announced today that its flagship Journal of Nuclear Medicine and the Journal of Nuclear Medicine Technology have moved to an open access publishing model, providing free, full-text online articles 12 months after publication.

"This represents a significant step toward maximum dissemination of significant, scholarly, peer-reviewed research of interest to the nuclear medicine, molecular imaging, and therapy community," said SNM President Martin P. Sandler, the associate vice chancellor for hospital affairs for Vanderbilt University Medical Center in Nashville, Tenn. "JNM--with its worldwide circulation and high impact and immediacy factors--is considered the most important and influential international journal in molecular imaging and therapy and nuclear medicine," said Sandler, who speaks for 16,000 physician, technologist and scientist society members. "Such unrestricted access to scientific knowledge is bound to have a major impact on medical practice and on promoting the benefits of molecular imaging and therapy," added Sandler. "This move coincides with the society's recent announcement of redefining its core mission 'to improve health care by advancing molecular imaging and therapy,'" he added.

"With digital open access, users are free to read, download, copy, distribute and print articles--with proper acknowledgement and citation," said Heinrich R. Schelbert, JNM's editor in chief. "This action speeds the delivery of important developments and innovations that significantly impact disease recognition, staging and management, thus expanding its audience to include medical researchers, physicians, technologists, other health care providers, patients and their advocates, students and the global public," said Schelbert, professor of molecular and medical pharmacology at the University of California at Los Angeles and the George V. Taplin professor at the university's David Geffen School of Medicine.

"With this action, accessibility to journal articles continues to remain high," said Beth A. Harkness, JNMT editor. "The Internet provides an economical and efficient conduit for delivery of important information," indicated Harkness, a physicist in the radiology department of the Henry Ford Health System in Detroit, Mich.

Since 1960, the monthly JNM has covered a broad spectrum of subjects from basic science and chemistry investigations to clinical studies, molecular biology, therapies, and advanced technologies, along with continuing medical education articles, invited perspectives and commentaries, procedure guidelines, book reviews and professional news. JNM's articles are consistently ranked among the world's most cited medical imaging research, and it is in the top 5 percent of other publications in its category and the more than 6,000 publications rated by the Thomson Institute for Scientific Information's Journal Citation Report.

Published since 1973, JNMT is a quarterly, peer-reviewed publication that focuses on technology, quality assurance, radiation safety, expert perspectives and clinical applications of nuclear medicine and molecular imaging.

SNM's board of directors approved the open access initiative at its 53rd Annual Meeting in San Diego. Open access does not bypass traditional publishing; rather, it is another form of access to already published material. JNM and JNMT open access articles are available on a Web site hosted by HighWire Press, a division of the Stanford University Libraries and Academic Information Resources. JNM and JNMT will be two of more than 800 scholarly journals posted on that site (http://jnm.snmjournals.org).
-end-
About SNM--Advancing Molecular Imaging and Therapy
SNM is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of molecular and nuclear imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNM continues to provide essential resources for health care practitioners and patients; publish the most prominent peer-reviewed journal in the field (the Journal of Nuclear Medicine); host the premier annual meeting for medical imaging; sponsor research grants, fellowships and awards; and train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances. SNM members have introduced--and continue to explore--biological and technological innovations in medicine that noninvasively investigate the molecular basis of diseases, benefiting countless generations of patients. SNM is based in Reston, Va.; additional information can be found online at http://www.snm.org.

Society of Nuclear Medicine

Related Molecular Imaging Articles from Brightsurf:

New technique offers higher resolution molecular imaging and analysis
The new approach from Northwestern Engineering could help researchers understand more complicated biomolecular interactions and characterize cells and diseases at the single-molecule level.

Molecular imaging offers insight into therapy outcomes for neuroendocrine tumor patients
A new proof-of-concept study published in the May issue of The Journal of Nuclear Medicine has demonstrated that molecular imaging can be used for identifying early response to 177Lu-DOTATATE treatment in neuroendocrine tumor patients.

Non-invasive imaging method spots cancer at the molecular level
Researchers for the first time have combined a powerful microscopy technique with automated image analysis algorithms to distinguish between healthy and metastatic cancerous tissue without relying on invasive biopsies or the use of a contrast dye.

Molecular imaging suggests smokers may have impaired neuroimmune function
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNM MI) shows preliminary evidence that tobacco smokers may have reduced neuroimmune function compared with nonsmokers.

Novel noninvasive molecular imaging for monitoring rheumatoid arthritis
A first-in-human Phase 1/Phase II study demonstrates that intravenous administration of the radiopharmaceutical imaging agent technetium-99m (99mTc) tilmanocept promises to be a safe, well-tolerated, noninvasive means of monitoring rheumatoid arthritis disease activity.

Improving molecular imaging using a deep learning approach
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed using a new deep learning approach to image reconstruction developed by researchers at Rensselaer Polytechnic Institute.

Nanoplatform developed with three molecular imaging modalities for tumor diagnosis
Nanotechnology and biotechnology are bringing us increasingly closer to personalised cancer treatment.

Study suggests molecular imaging strategy for determining molecular classifications of NSCLC
Recent findings suggest a novel positron emission tomography (PET) imaging approach determining epidermal growth factor receptor (EGFR) mutation status for improved lung cancer patient management.

New imaging technique able to watch molecular dynamics of neurodegenerative diseases
Researchers have developed a fast and practical molecular-scale imaging technique that could let scientists view never-before-seen dynamics of biological processes involved in neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis.

Combined optical and molecular imaging could guide breast-conserving surgery
Breast-conserving surgery is the primary treatment for early-stage breast cancer, but more accurate techniques are needed to assess resection margins during surgery to avoid the need for follow-up surgeries.

Read More: Molecular Imaging News and Molecular Imaging Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.